Meyka AI API is live for developers.Start building.
Advertisement
Hikma Pharmaceuticals PLC

Hikma Pharmaceuticals PLC (HKMPY) Stock Overview

Explore Hikma Pharmaceuticals PLC’s financial performance, market position, analyst ratings, and future outlook.

HKMPY●PNK
HealthcareDrug Manufacturers - Specialty & Generic
$39.27
$0.27(0.69%)
U.S. Market opens in 46h 46m
Advertisement

Hikma Pharmaceuticals PLC (HKMPY)

Meyka AI Score

Z

Key Financials

Market Cap4.3B
P/E Ratio10.77
EPS (TTM)$3.62
ROE0.16%
Fundamental Analysis

AI Price Forecasts

1 Month$38.89
3 Months$33.54
1 Year Target$35.20

HKMPY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Hikma Pharmaceuticals PLC (HKMPY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 75.18, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $35.20.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 10.77 and a market capitalization of 4.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.69%
5-Day Change
0.23%
1-Month Change
5.54%
3-Month Change
20.76%
6-Month Change
-8.10%
Year-to-Date (YTD) Change
-6.34%
1-Year Change
-31.00%
3-Year Change
-12.87%
5-Year Change
-43.90%
All-Time (Max) Change
61.74%

Contact Information

https://www.hikma.com
44 20 7399 2760
1 New Burlington Place, London, NaN, W1S 2HR

Company Facts

9,500 Employees
IPO DateFeb 7, 2012
CountryGB
Actively Trading

Frequently Asked Questions